Humanized anti-DEspR IgG4(S228P) antibody increases overall survival in a pancreatic cancer stem cell-xenograft peritoneal carcinomatosis rat(nu/nu) model

BACKGROUND: Pancreatic peritoneal carcinomatosis (PPC), with the worst median overall-survival (mOS), epitomizes the incurability of metastatic cancer. Cancer stem cells (CSCs) underpin this incurability. However, inhibitors of CSC-stemness fail to increase mOS in cancer patients despite preclinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Gromisch, Christopher M., Tan, Glaiza L. A., Pasion, Khristine Amber, Moran, Ann-Marie, Gromisch, Matthew S., Grinstaff, Mark W., Carr, Francis J., Herrera, Victoria L. M., Ruiz-Opazo, Nelson
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8048286/
https://www.ncbi.nlm.nih.gov/pubmed/33853558
http://dx.doi.org/10.1186/s12885-021-08107-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8048286/
https://www.ncbi.nlm.nih.gov/pubmed/33853558
http://dx.doi.org/10.1186/s12885-021-08107-w

Ejemplares similares